MetaVia’s DA-1726 shows liver, weight benefits in preclinical study
MetaVia Inc. presented preclinical head-to-head data at ObesityWeek 2026 in Washington, D.C., comparing DA-1726 with retatrutide. The post MetaVia’s DA-1726 shows liver, weight benefits in preclinical study appeared first on Longevity.Technology.

<p>MetaVia Inc. presented preclinical head-to-head data at ObesityWeek 2026 in Washington, D.C., comparing DA-1726 with retatrutide.
The post MetaVia’s DA-1726 shows liver, weight benefits in preclinical study appeared first on Longevity.Technology.</p>